Table 6 Discriminatory ability (ISSAS database): standardised mean difference between patients requiring/not requiring anti-TNF therapy
TNF Yes (n = 358) Mean (SD)TNF No (n = 350) Mean (SD)Standardised mean difference
ASDAS A3.87 (1.01)2.71 (0.96)1.18
ASDAS B3.52 (0.97)2.43 (0.95)1.14
ASDAS C3.49 (0.99)2.44 (0.98)1.07
ASDAS D3.94 (1.02)2.81 (0.96)1.14
BASDAI5.45 (2.05)3.75 (2.17)0.81
Ln (CRP+1)2.72 (1.07)1.99 (0.96)0.71
CRP (mg/l)*, median (range)13 (0.50–120)3 (0.50–80)
√(ESR)5.45 (2.09)3.87 (1.72)0.82
ESR* (median, range)25.5 (1–88)12 (1–66)
Ln (swollen joint count+1)0.55 (0.81)0.30 (0.60)0.35
Swollen joint count*, median (range)0 (0–12)0 (0–10)
√(Tender enthesis count)1.78 (1.38)1.14 (1.26)0.48
Tender enthesis count*, median (range)2.5 (0–24)0 (0–10)
Back pain at night5.10 (2.80)3.33 (2.60)0.65
Total spinal pain (pain spine)5.32 (2.57)3.69 (2.47)0.65
Patient global assessment6.05 (2.43)4.02 (2.55)0.81
BASDAI question 1 (fatigue)5.88 (2.60)3.75 (2.17)0.89
BASDAI question 2 (back pain)6.52 (2.51)4.50 (2.66)0.79
BASDAI question 3 (peripheral pain/swelling)4.22 (3.14)4.67 (2.69)−0.16
BASDAI question 6 (duration of morning stiffness)5.26 (3.07)4.05 (2.86)0.41
BASFI5.29 (2.50)3.35 (2.54)0.77
  • *For information purposes only, actual values are presented.

  • ASDAS, Ankylosing Spondylitis Disease Activity Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ISSAS, International Study on Starting TNF blocking agents in Ankylosing Spondylitis; TNF, tumour necrosis factor.